Analyzing the Role of Levofloxacin in Urinary Tract Infections-A review Dr. Kamal Kant Kohli29 Jun 2022 12:45 PM ISTAffecting 150 million people each year worldwide (1), urinary tract infections (UTIs) are regarded to be among the most common causes of sepsis...
Management of Allergic Rhinitis during COVID-19 Pandemic Dr. Kamal Kant Kohli27 Jun 2022 12:00 PM ISTThe COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) has challenged the healthcare systems and altered the...
Role of Probiotics in recurrent bacterial vaginosis: A review Dr Sachin M. Lokhande25 Jun 2022 12:58 PM ISTBacterial vaginosis (BV) has been documented to be the most common urogenital infection in women of reproductive age, with estimates highlighting that...
Decoding the correct diagnosis of Allergic Rhinitis in clinic practice - Dr Tushar Kanti Ghosh DR. TUSHAR KANTI GHOSH21 Jun 2022 12:45 PM IST Advertisement Allergic rhinitis is an Immunoglobulin E (IgE)-mediated disorder of the nose, usually caused by sensitization...
Bronchial Asthma - Early Indicators for Diagnosis and Its Management in Indian Practice Settings Dr. Kamal Kant Kohli17 Jun 2022 12:45 PM ISTBronchial Asthma-Indian PerspectiveAsthma is a chronic inflammatory airway disease associated with airway remodeling; augmenting its smooth muscle...
Role of metoprolol tartrate in management of acute myocardial infarction in the present era dr. Abhimanyu Uppal15 Jun 2022 11:00 AM ISTIt has long been known that among patients with acute myocardial infarction (MI), beta-blocker therapy is beneficial in reducing infarct size and...
Managing co-existing allergic rhinitis and asthma: Analyzing the role of Montelukast-levocetirizine combination Dr. Kamal Kant Kohli13 Jun 2022 12:41 PM ISTAllergic rhinitis (AR) is now being acknowledged as a global health burden with estimates highlighting that 10%-25% of the population worldwide is...
Casirivimab/Imdevimab - An Indian Real World Experience : Review Dr. Kamal Kant Kohli10 Jun 2022 11:49 AM ISTThe antibody cocktail (Casirivimab and Imdevimab) has been approved in India for the treatment of mild to moderate COVID-19 in adolescents and adults...
Anti-diabetic drug and NASH: Current Options in 2022 Dr. Kamal Kant Kohli9 Jun 2022 11:06 AM ISTIntroduction and Background Nonalcoholic steatohepatitis (NASH) is a more aggressive form of nonalcoholic fatty liver disease, which can increase the...
Novel therapies in managing Allergic rhinitis: How far have we come? Dr. Kamal Kant Kohli8 Jun 2022 12:45 PM ISTAllergic rhinitis(AR) is a common respiratory condition affecting 40 % of the worldwide population. Due to its shared pathophysiology with...
Understanding the scope of Faropenem in Lower Respiratory Tract Infections(LRTIs) Dr. Kamal Kant Kohli1 Jun 2022 11:03 AM ISTLower Respiratory Infections(LRIs): Complexities in the Indian ContextIn India, the burden of lower respiratory tract infections (LRTIs) is...
Decoding the Management of Otitis Media and Role of Amoxicillin Dr. Kamal Kant Kohli27 May 2022 12:30 PM ISTAcute otitis media (AOM) - an infection of the middle ear, is the second most common pediatric diagnosis in the primary and emergency care department...
